• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白血病突变蛋白PHF6和PHIP形成一种染色质复合物,可抑制急性髓系白血病干性。

Leukemia mutated proteins PHF6 and PHIP form a chromatin complex that represses acute myeloid leukemia stemness.

作者信息

Pawar Aishwarya S, Somers Patrick, Alex Aleena, Grana Jason, Feist Victoria K, George Subin S, Jalnapurkar Sapana S, Antony Charles, Verner Roman, White-Brown Sanese K, Khera Mohit, Mendoza-Figueroa María Saraí, Liu Kathy Fange, Morrissette Jennifer J D, Gurbuxani Sandeep, Paralkar Vikram R

机构信息

Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA.

Biomedical Graduate Studies, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA.

出版信息

Genes Dev. 2025 Jul 28. doi: 10.1101/gad.352602.125.

DOI:10.1101/gad.352602.125
PMID:40721297
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12340699/
Abstract

Myeloid leukemias are heterogeneous cancers with diverse mutations, sometimes in genes with unclear roles and unknown functional partners. PHF6 and PHIP are two poorly understood chromatin-binding proteins recurrently mutated in acute myeloid leukemia (AML). mutations are associated with poorer outcomes, whereas was recently identified as the most common selective mutation in Black patients with AML. Here, we show that knockout converts -driven mouse chronic myelomonocytic leukemia (CMML) into AML with reduced survival. Using cell line models, we show that PHF6 is a transcriptional repressor that suppresses a limited stemness gene network and that missense mutations, classified by current clinical algorithms as variants of unknown significance, produce unstable or nonfunctional protein. We present multiple lines of evidence converging on a critical mechanistic connection between PHF6 and PHIP. We show that loss phenocopies loss and that PHF6 requires PHIP to occupy chromatin and exert its downstream transcriptional program. Our work unifies PHF6 and PHIP, two disparate leukemia mutated proteins, into a common functional complex that suppresses AML stemness.

摘要

髓系白血病是具有多种突变的异质性癌症,这些突变有时发生在作用不明且功能伙伴未知的基因中。PHF6和PHIP是两种在急性髓系白血病(AML)中经常发生突变但了解较少的染色质结合蛋白。这些突变与较差的预后相关,而最近PHF6被确定为黑人AML患者中最常见的选择性突变。在这里,我们表明敲除PHF6会将PHIP驱动的小鼠慢性粒单核细胞白血病(CMML)转化为生存期缩短的AML。使用细胞系模型,我们表明PHF6是一种转录抑制因子,可抑制有限的干性基因网络,并且根据当前临床算法分类为意义未明变异体的PHF6错义突变会产生不稳定或无功能的蛋白质。我们提供了多条证据,表明PHF6和PHIP之间存在关键的机制联系。我们表明,PHF6缺失模拟了PHIP缺失,并且PHF6需要PHIP才能占据染色质并发挥其下游转录程序。我们的工作将PHF6和PHIP这两种不同的白血病突变蛋白统一到一个抑制AML干性的共同功能复合物中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/9170c48e7eb8/nihms-2100805-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/04420bc1ec52/nihms-2100805-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/5352f4d77881/nihms-2100805-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/452e757c88c0/nihms-2100805-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/cea743d5ae2e/nihms-2100805-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/7cfa81967569/nihms-2100805-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/f73fc52a90cd/nihms-2100805-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/9170c48e7eb8/nihms-2100805-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/04420bc1ec52/nihms-2100805-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/5352f4d77881/nihms-2100805-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/452e757c88c0/nihms-2100805-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/cea743d5ae2e/nihms-2100805-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/7cfa81967569/nihms-2100805-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/f73fc52a90cd/nihms-2100805-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa4/12340699/9170c48e7eb8/nihms-2100805-f0007.jpg

相似文献

1
Leukemia mutated proteins PHF6 and PHIP form a chromatin complex that represses acute myeloid leukemia stemness.白血病突变蛋白PHF6和PHIP形成一种染色质复合物,可抑制急性髓系白血病干性。
Genes Dev. 2025 Jul 28. doi: 10.1101/gad.352602.125.
2
Leukemia-mutated proteins PHF6 and PHIP form a chromatin complex that represses acute myeloid leukemia stemness.白血病突变蛋白PHF6和PHIP形成一种染色质复合物,可抑制急性髓系白血病干性。
bioRxiv. 2024 Dec 18:2024.11.29.625909. doi: 10.1101/2024.11.29.625909.
3
Clinical Characteristics and Outcomes of Acute Myeloid Leukemia Patients Harboring Triple Mutations and the Potential Prognostic Value of .携带三重突变的急性髓系白血病患者的临床特征与预后及……的潜在预后价值
Cancer Control. 2025 Jan-Dec;32:10732748251359836. doi: 10.1177/10732748251359836. Epub 2025 Jul 17.
4
Myeloid neoplasms with PHF6 mutations: context-dependent genomic and prognostic characterization in 176 informative cases.伴有PHF6突变的髓系肿瘤:176例信息充分病例的背景依赖性基因组和预后特征分析
Blood Cancer J. 2025 Mar 1;15(1):28. doi: 10.1038/s41408-025-01231-x.
5
PHF6 and RUNX1 mutations cooperate to accelerate leukemogenesis.PHF6和RUNX1突变共同作用以加速白血病发生。
Transl Oncol. 2025 Sep;59:102449. doi: 10.1016/j.tranon.2025.102449. Epub 2025 Jun 26.
6
A new link in the leukemia genetic puzzle.白血病基因难题中的一个新环节。
Genes Dev. 2025 Aug 12. doi: 10.1101/gad.353189.125.
7
Ningetinib, a novel FLT3 inhibitor, overcomes secondary drug resistance in acute myeloid leukemia.奈拉替尼,一种新型的 FLT3 抑制剂,克服了急性髓系白血病的继发性耐药。
Cell Commun Signal. 2024 Jul 8;22(1):355. doi: 10.1186/s12964-024-01729-0.
8
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
9
Foretinib Is Effective in Acute Myeloid Leukemia by Inhibiting FLT3 and Overcoming Secondary Mutations That Drive Resistance to Quizartinib and Gilteritinib.福瑞替尼通过抑制 FLT3 并克服导致对 Quizartinib 和 Gilteritinib 耐药的继发突变,在急性髓系白血病中有效。
Cancer Res. 2024 Mar 15;84(6):905-918. doi: 10.1158/0008-5472.CAN-23-1534.
10
BRCC36 associates with FLT3-ITD to regulate its protein stability and intracellular signaling in acute myeloid leukemia.BRCC36 通过与 FLT3-ITD 相互作用来调节急性髓系白血病中其蛋白稳定性和细胞内信号转导。
Cancer Sci. 2024 Apr;115(4):1196-1208. doi: 10.1111/cas.16090. Epub 2024 Jan 30.

本文引用的文献

1
Bcl11a maintains hematopoietic stem cell function but accelerates inflammation-driven exhaustion during aging.Bcl11a维持造血干细胞功能,但在衰老过程中加速炎症驱动的耗竭。
Sci Immunol. 2025 Apr 11;10(106):eadr2041. doi: 10.1126/sciimmunol.adr2041.
2
Novel Insights: A Novel PHIP Variant in a Family with Severe Early-Onset Obesity.新见解:一个患有严重早发性肥胖症的家族中的一种新型PHIP变异体。
Horm Res Paediatr. 2024 Oct 22:1-8. doi: 10.1159/000542205.
3
Multiomic profiling identifies predictors of survival in African American patients with acute myeloid leukemia.
多组学分析鉴定出非裔美国人急性髓系白血病患者生存的预测因子。
Nat Genet. 2024 Nov;56(11):2434-2446. doi: 10.1038/s41588-024-01929-x. Epub 2024 Oct 4.
4
PHF6 cooperates with SWI/SNF complexes to facilitate transcriptional progression.PHF6 与 SWI/SNF 复合物合作,促进转录延伸。
Nat Commun. 2024 Aug 24;15(1):7303. doi: 10.1038/s41467-024-51566-5.
5
Pathogenic PHIP Variants are Variably Associated With CAKUT.致病性PHIP变异与先天性肾脏和尿路畸形(CAKUT)存在不同程度的关联。
Kidney Int Rep. 2024 May 27;9(8):2484-2497. doi: 10.1016/j.ekir.2024.05.024. eCollection 2024 Aug.
6
PHF6 suppresses self-renewal of leukemic stem cells in AML.PHF6 抑制 AML 中的白血病干细胞自我更新。
Leukemia. 2024 Sep;38(9):1938-1948. doi: 10.1038/s41375-024-02340-5. Epub 2024 Jul 14.
7
The detection of a strong episignature for Chung-Jansen syndrome, partially overlapping with Börjeson-Forssman-Lehmann and White-Kernohan syndromes.检测到 Chung-Jansen 综合征的强烈附加特征,与 Börjeson-Forssman-Lehmann 和 White-Kernohan 综合征部分重叠。
Hum Genet. 2024 Jun;143(6):761-773. doi: 10.1007/s00439-024-02679-w. Epub 2024 May 24.
8
Molecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting.PHF6 突变性髓系肿瘤的分子和临床分析为其发病机制和治疗靶点提供了依据。
Nat Commun. 2024 Feb 28;15(1):1832. doi: 10.1038/s41467-024-46134-w.
9
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.骨髓增生异常综合征的分子国际预后评分系统
NEJM Evid. 2022 Jul;1(7):EVIDoa2200008. doi: 10.1056/EVIDoa2200008. Epub 2022 Jun 12.
10
DCAF14 regulates CDT2 to promote SET8-dependent replication fork protection.DCAF14 通过调控 CDT2 促进 SET8 依赖的复制叉保护。
Life Sci Alliance. 2023 Nov 8;7(1). doi: 10.26508/lsa.202302230. Print 2024 Jan.